Researchers Develop Promising Therapy Treatment That Can Kill Glioblastoma Cells in Newly ... and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study ...

Once given a diagnosis of a brain metastasis or malignant glioma, patients were sent home to die. Cushing and Bailey described glioblastoma multiforme (GBM) in 1926: "It is from this group ...

The main progress will probably come from integrated high-throughput studies of the glioma genome ... proposed a molecular classification of glioblastoma in several subtypes: this will also ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients survive ...

A pioneering research study announced today (October 23) will trial multiple new treatments for people in the UK living with ...

The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year.

In particular, the research team concentrated on the molecular characteristics underlying tumor progression and recurrence of two gliomas: glioblastoma and IDH-mutant grade 4 astrocytoma.

While gliomas usually grow in the brain they can also form in the spinal cord. They are also difficult to reach and treat ...

Their treatment still relies on surgery, chemotherapy and radiotherapy, and malignant gliomas – which include diseases like glioblastoma multiforme (GBM) – are usually fatal within two years ...

The FDA accepted the new drug application for TLX101-CDx and granted priority review to the agent in glioma. The FDA has ...